The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.

A delegation from the Vietnam - France Friendship and Cooperation Association (AACVF) led by Assoc. Prof. Dr Nguyen Thi Kim Tien, former Health Minister of Vietnam and Honorary President of the AACVF, paid a working visit to France from October 6 - 10 to seek stronger cooperation between the two countries in the fields of health care and pharmaceuticals.

The Vietnam Vaccine Joint Stock Company (VNVC) and Sanofi on October 8 signed a document guiding the cooperation in manufacturing some vaccines of the French pharmaceutical group in the Southeast Asian country.

The Pasteur Institute in Ho Chi Minh City ad Sanofi Vietnam have signed a partnership agreement to implement a training strategy entitled “Vaccinology and Life-course Immunisation” for healthcare professionals in Vietnam from 2023 to 2025.

TTi Group has proposed developing a solar battery manufacturing plant, expected to cost 150 million USD, at Sai Gon Hi-tech Park (SHTP) in Ho Chi Minh City.

The Philippines said it has suspended use of Dengvaxia vaccine against dengue virus after its manufacturer warned it could worsen the disease in some cases.